(Q38837164)

6 September 2017

title

Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells (English)

1 reference

Correction to: Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells

6 September 2017

corrigendum / erratum

0 references

Rasoul Ghasemi

2

0 references

Maryam Moosavi

object named as

Maryam Moosavi

series ordinal

3

0 references

author name string

Esmat Amiri

series ordinal

1

1 reference

6 September 2017

publication date

7 September 2015

1 reference

Cellular and Molecular Neurobiology

6 September 2017

published in

1 reference

6 September 2017

volume

36

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

829-838

1 reference

The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

The arginine metabolite agmatine protects mitochondrial function and confers resistance to cellular apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine prevents the Ca(2+)-dependent induction of permeability transition in rat brain mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Extracellular toxicity of 6-hydroxydopamine on PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Counting on mitogen-activated protein kinases--ERKs 3, 4, 5, 6, 7 and 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Toxin-induced models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

The possible role of intracellular polyamines in mitochondrial metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Oxidative neuronal injury. The dark side of ERK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine effects on mitochondrial membrane potential and NF-κB activation protect against rotenone-induced cell damage in human neuronal-like SH-SY5Y cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Protective effects of agmatine in rotenone-induced damage of human SH-SY5Y neuroblastoma cells: fourier transform infrared spectroscopy analysis in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Glycogen Synthase Kinase-3 from Rabbit Skeletal Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine induces Nrf2 and protects against corticosterone effects in hippocampal neuronal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Akt as a victim, villain and potential hero in Parkinson's disease pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Role of oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

The antiproliferative effects of agmatine correlate with the rate of cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine promotes the migration of murine brain endothelial cells via multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine reduces hydrogen peroxide in mesangial cells under high glucose conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Autoradiographic demonstration of uptake and accumulation of3H-6-hydroxydopamine in adrenergic nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

3-isobutylmethylxanthine inhibits hepatic urea synthesis: protection by agmatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Emerging roles of caspase-3 in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Mitogen-activated protein kinases contribute to reactive oxygen species-induced cell death in renal proximal tubule epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Is agmatine a novel neurotransmitter in brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

ERK1/2 MAP kinases: structure, function, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Can cellular models revolutionize drug discovery in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP⁺, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

ERK and cell death: ERK1/2 in neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53's transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Requirement for ERK activation in cisplatin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine protects against cell damage induced by NMDA and glutamate in cultured hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Effects of insulin-like growth factor-1 on okadaic acid-induced apoptosis in SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Activation of phosphatidylinositol 3-kinase/Akt signaling pathway and endogenous nitric oxide are needed for the antiarrhythmic effect of centrally administered rilmenidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

A death-promoting role for extracellular signal-regulated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10571-015-0266-7

Inhibition of the bioenergetic functions of isolated rat liver mitochondria by polyamines

21 January 2018

1 reference

12 December 2020

Proceedings: The effect of delta-1-tetrahydrocannabinol on the noradrenaline and dopamine content of the brain and heart of the rat

1 reference

12 December 2020

Different behavior of agmatine in liver mitochondria: inducer of oxidative stress or scavenger of reactive oxygen species?

1 reference

12 December 2020

Activation of protein kinase B/Akt and endothelial nitric oxide synthase mediates agmatine-induced endothelium-dependent relaxation

1 reference

12 December 2020

Protective effect of (+/-) isoborneol against 6-OHDA-induced apoptosis in SH-SY5Y cells

1 reference

12 December 2020

[Detection of cell apoptosis by MTT assay].

1 reference

12 December 2020

Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase

1 reference

12 December 2020

Polyamine transport system mediates agmatine transport in mammalian cells

1 reference

12 December 2020

Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins

1 reference

12 December 2020

Neuropathology of Parkinson's disease

1 reference

12 December 2020

10.1007/S10571-015-0266-7

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1018696643

0 references

1 reference